Expand AMRX Menu
AMRX MENU

AMRX Latest Press Releases

-- April 9, 2026 --

Amneal Launches Bimatoprost Ophthalmic Solution, 0.01% Globe Newswire 8:00 AM

-- April 7, 2026 --

Amneal to Report First Quarter 2026 Results on May 1, 2026 Globe Newswire 4:01 PM
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson's Awareness Month Globe Newswire 8:00 AM

-- March 5, 2026 --

Amneal to Participate in Upcoming Investor Conference Globe Newswire 4:05 PM

-- February 27, 2026 --

Amneal Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 6:00 AM

-- January 28, 2026 --

Amneal Pharmaceuticals Added to S&P SmallCap 600 Index Globe Newswire 4:05 PM

-- January 27, 2026 --

TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600 PRNewswire 6:03 PM
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 Globe Newswire 8:00 AM

-- January 9, 2026 --

KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson's Disease Business Wire 11:00 AM

-- December 9, 2025 --

Amneal Receives U.S. FDA Approval for Epinephrine Injection in Single- and Multi-Dose Vials for U.S. Hospitals Globe Newswire 4:01 PM

-- December 5, 2025 --

Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT for Parkinson's Disease Globe Newswire 8:00 AM

-- December 2, 2025 --

Amneal to Participate in Upcoming Investor Conferences Globe Newswire 8:00 AM
Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol Globe Newswire 8:00 AM

-- December 1, 2025 --

Amneal Announces U.S. FDA Approval of Cyclosporine Ophthalmic Emulsion 0.05% Globe Newswire 4:01 PM

-- November 13, 2025 --

Amneal Receives U.S. FDA Approval for Iohexol Injection Globe Newswire 4:01 PM
Market Data Delayed 15 Minutes